CN101688871A - 测量用药物洗脱支架治疗的个体的血小板反应性的方法 - Google Patents

测量用药物洗脱支架治疗的个体的血小板反应性的方法 Download PDF

Info

Publication number
CN101688871A
CN101688871A CN200880022878A CN200880022878A CN101688871A CN 101688871 A CN101688871 A CN 101688871A CN 200880022878 A CN200880022878 A CN 200880022878A CN 200880022878 A CN200880022878 A CN 200880022878A CN 101688871 A CN101688871 A CN 101688871A
Authority
CN
China
Prior art keywords
platelet
particle
adp
patient
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880022878A
Other languages
English (en)
Chinese (zh)
Inventor
巴里·S·科勒
丹尼斯·德宾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Accumetrics Inc
Original Assignee
Accumetrics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accumetrics Inc filed Critical Accumetrics Inc
Publication of CN101688871A publication Critical patent/CN101688871A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/222—Platelet disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN200880022878A 2007-05-01 2008-05-01 测量用药物洗脱支架治疗的个体的血小板反应性的方法 Pending CN101688871A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/742,684 2007-05-01
US11/742,684 US20070243632A1 (en) 2003-07-08 2007-05-01 Methods for measuring platelet reactivity of patients that have received drug eluting stents
PCT/US2008/062297 WO2008137600A1 (en) 2007-05-01 2008-05-01 Methods for measuring platelet reactivity of individuals treated with drug eluting stents

Publications (1)

Publication Number Publication Date
CN101688871A true CN101688871A (zh) 2010-03-31

Family

ID=39615637

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880022878A Pending CN101688871A (zh) 2007-05-01 2008-05-01 测量用药物洗脱支架治疗的个体的血小板反应性的方法

Country Status (6)

Country Link
US (2) US20070243632A1 (cg-RX-API-DMAC7.html)
EP (1) EP2145192A1 (cg-RX-API-DMAC7.html)
JP (1) JP5687055B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100017510A (cg-RX-API-DMAC7.html)
CN (1) CN101688871A (cg-RX-API-DMAC7.html)
WO (1) WO2008137600A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105203752A (zh) * 2015-11-05 2015-12-30 上海中山医疗科技发展公司 一种磁性血小板吸附颗粒及其制备方法
CN105717263A (zh) * 2016-03-04 2016-06-29 北京乐普医疗科技有限责任公司 一种检测噻吩并吡啶类抗血小板药物疗效的试剂卡及其使用方法和应用
CN107430645A (zh) * 2015-04-08 2017-12-01 皇家飞利浦有限公司 用于重症监护病房中的实验室值自动化分析和风险通知的系统

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7790362B2 (en) * 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
US7595169B2 (en) * 2005-04-27 2009-09-29 Accumetrics, Inc. Method for determining percent platelet aggregation
US20080299587A1 (en) * 2007-05-03 2008-12-04 Dennis Durbin Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
US8448499B2 (en) 2008-12-23 2013-05-28 C A Casyso Ag Cartridge device for a measuring system for measuring viscoelastic characteristics of a sample liquid, a corresponding measuring system, and a corresponding method
EP2371284A1 (en) * 2010-03-24 2011-10-05 C A Casyso AG Method and apparatus for determining at least one evaluation parameter of a blood sample
RU2442167C1 (ru) * 2010-07-21 2012-02-10 Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" Способ оценки эффективности действия антиагрегантных препаратов, влияющих на метаболизм арахидоновой кислоты путем ингибирования циклооксигеназы-1 как в отдельности, так и совместно с антагонистом рецептора адф p2y12 на тромбоцитарных мембранах, на состояния тромбоцитов крови пациента, принимающего антиагрегантные препараты указанной группы
JP5768422B2 (ja) * 2011-03-17 2015-08-26 ソニー株式会社 血液凝固系解析方法および血液凝固系解析装置
EP2508892A1 (de) * 2011-04-04 2012-10-10 Siemens Healthcare Diagnostics Products GmbH Kontrollen und Kit für Thrombozytenaktivitätsteste
DE102014112270B3 (de) * 2014-08-27 2015-04-23 Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V. Verfahren zur Messung der Thrombozytenfunktion
US10816559B2 (en) 2014-09-29 2020-10-27 Ca Casyso Ag Blood testing system and method
US10539579B2 (en) 2014-09-29 2020-01-21 C A Casyso Gmbh Blood testing system and method
GB201503425D0 (en) * 2015-02-27 2015-04-15 Randox Lab Ltd Prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention
EP4274625A1 (en) * 2021-01-07 2023-11-15 Baxter International Inc. Thrombin-free hemostatic materials, methods of manufacture, and uses thereof
WO2023238136A1 (en) * 2022-06-08 2023-12-14 Ichilov Tech Ltd. Methods of assessing platelet aggregation

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US409758A (en) * 1889-08-27 Velocipede
US3518057A (en) * 1966-04-22 1970-06-30 Huron Road Hospital Method and apparatus for thrombus formation time determinations
US3694161A (en) * 1971-04-14 1972-09-26 Armour Pharma Method for measuring platelet aggregation
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4051236A (en) * 1973-02-15 1977-09-27 E. R. Squibb & Sons, Inc. Inhibition of blood platelet aggregation
FI58700C (fi) * 1974-02-21 1981-03-10 Braun Melsungen Ag Foerfarande foer maetning av blodplaettars spontanaaggregation i blodplaettsrik citratplasma
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
JPS5697226A (en) 1979-12-28 1981-08-05 Mitsubishi Chem Ind Ltd Blood platelet coagulation inhibitor
US4622293A (en) 1983-07-05 1986-11-11 Miles Laboratories, Inc. Iodothyronine immunoassays employing HMS as TBP blocking agent
US4717654A (en) 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay
US4619904A (en) * 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4634681A (en) * 1984-10-29 1987-01-06 General Electric Company Diagnostic method of determining the presence or absence of select proteins in a liquid sample
US4948961A (en) 1985-08-05 1990-08-14 Biotrack, Inc. Capillary flow device
CA1284642C (en) * 1986-03-31 1991-06-04 Hikozo Iwakura Prostacyclin (pgi ) analogues
DE3717337A1 (de) * 1987-05-22 1988-12-15 Hoechst Ag Verfahren zum nachweis der antiaggregatorischen wirkung von vasoaktiven stoffen, speziell von phosphodiesterase- und/oder cyclooxygenase-hemmern
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
US5066592A (en) * 1988-03-08 1991-11-19 Temple University Of The Commonwealth System Of Higher Education Trigramin - a platelet aggregation inhibiting polypeptide
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0527818A4 (en) 1990-04-30 1993-09-15 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of arachidonic acid metabolism
US5246832A (en) * 1990-06-20 1993-09-21 University Of Massachusetts Medical Center Platelet analysis in whole blood
US5196309A (en) 1990-11-15 1993-03-23 The Scripps Research Institute Characterization of platelet aggregation disorders
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5688768A (en) 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
US5427913A (en) * 1992-12-03 1995-06-27 Alberta Cancer Board Methods for determining platelet function
AU7112794A (en) 1993-06-18 1995-01-17 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5455228A (en) * 1993-07-02 1995-10-03 The Research Foundation Of State University Of New York Peptidase resistant thrombin receptor peptide ligand
IL106330A (en) * 1993-07-14 1998-01-04 Univ Ramot Method and instrument for determining the activity of their plaques in the initial coagulation system
US5486361A (en) * 1993-10-25 1996-01-23 The United States Of America As Represented By The Department Of Health And Human Services Hybridomas and monoclonal antibodies that speifically bind to GPIB on platelets and inhibit the binding of thrombin to platelets
DE4344919A1 (de) 1993-12-30 1995-07-06 Behringwerke Ag Verfahren zur Bestimmung der Thrombozytenaggregation
WO1995027209A1 (en) 1994-03-31 1995-10-12 The Trustees Of The University Of Pennsylvania Method and kit for detection of thrombin receptor activation of platelets and other cells
ES2139957T3 (es) 1994-07-23 2000-02-16 Roche Diagnostics Gmbh Metodo para la determinacion del estado pretrombotico.
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
US5952006A (en) 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
FR2744918B1 (fr) * 1996-02-19 1998-05-07 Sanofi Sa Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
US5753517A (en) * 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US6221672B1 (en) * 1996-04-30 2001-04-24 Medtronic, Inc. Method for determining platelet inhibitor response
US6043871A (en) * 1997-03-03 2000-03-28 Brigham Young University System and method for measuring blood platelet function
US5922551A (en) * 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6016712A (en) * 1997-09-18 2000-01-25 Accumetrics Device for receiving and processing a sample
US6210904B1 (en) * 1997-10-14 2001-04-03 Merck & Co., Inc. Anticoagulant test
JP4309045B2 (ja) 1997-10-30 2009-08-05 森下仁丹株式会社 不飽和脂肪酸またはその誘導体を内容物とするカプセル製剤およびその製造法
US6063847A (en) * 1997-11-25 2000-05-16 Schering Corporation Thrombin receptor antagonists
USD409758S (en) * 1998-01-14 1999-05-11 Accumetrics Sample cartridge
CA2321142A1 (en) 1998-02-27 1999-09-02 Regents Of The University Of California Protease-activated receptor 4 and uses thereof
EP0964046B1 (en) * 1998-06-03 2003-07-30 Mitsubishi Gas Chemical Company, Inc. Oxygen absorbing composition, oxygen absorbing resin and preserving method
US6093370A (en) * 1998-06-11 2000-07-25 Hitachi, Ltd. Polynucleotide separation method and apparatus therefor
US6387645B1 (en) * 1998-07-16 2002-05-14 Hyseq, Inc. Methods and materials relating to novel CD39-like polypeptides
CN1189166C (zh) 1998-09-11 2005-02-16 伊来克萨斯独资有限公司 Fc受体调节剂及其应用
CA2348612A1 (en) 1998-10-23 2000-05-04 Barry S. Coller Method for determining platelet count
AU5044400A (en) 1999-05-28 2000-12-18 Sendx Medical, Inc. Control for methods for determining platelet count and platelet function
JP2003509478A (ja) * 1999-09-21 2003-03-11 エモリー・ユニバーシティ 血小板関連障害を処置する方法および組成物
US6994983B2 (en) * 1999-10-25 2006-02-07 Esoterix, Inc. Coagulation Kits for determination of thromboxane B2 metabolite and optimizing aspirin dosage
US6589992B2 (en) * 1999-11-30 2003-07-08 Parker Hughes Institute Inhibiting collagen-induced platelet aggregation
JP2004507456A (ja) 2000-05-11 2004-03-11 ブリストル−マイヤーズ スクイブ カンパニー 成長ホルモン分泌促進薬として有用なテトラヒドロイソキノリン類縁体
KR100604742B1 (ko) * 2000-06-15 2006-07-26 쉐링 코포레이션 트롬빈 수용체 길항제
US20020077693A1 (en) * 2000-12-19 2002-06-20 Barclay Bruce J. Covered, coiled drug delivery stent and method
WO2002026109A2 (en) 2000-09-29 2002-04-04 Endovasc Ltd., Inc. Resorbable prosthesis for medical treatment
EP1331228B1 (en) 2000-11-01 2007-03-21 Astellas Pharma Inc. Method of screening antiplatelet
US6841354B2 (en) * 2000-12-21 2005-01-11 Philadelphia, Health & Education Corporation Screening assay for anti-thrombotic/anti-platelet activity
RU2270192C2 (ru) * 2001-04-19 2006-02-20 Эйсай Ко., Лтд. Производные 2-иминопирролидина
WO2003004604A2 (en) 2001-07-06 2003-01-16 Genentech, Inc. Phage displayed pdz domain ligands
CA2463628A1 (en) * 2001-10-18 2003-04-24 Schering Corporation Himbacine analogues as thrombin receptor antagonists
US6833536B2 (en) * 2002-05-22 2004-12-21 Applera Corporation Non-contact radiant heating and temperature sensing device for a chemical reaction chamber
FR2840409B1 (fr) * 2002-05-28 2004-08-27 Dev Des Antigenes Combinatoire Dispositif de presentation de peptides ou de proteines, son procede de preparation et ses utilisations
US7438925B2 (en) * 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
US20050019742A1 (en) 2002-10-15 2005-01-27 Jennings Lisa K. Methods for assessment of platelet aggregation
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7790362B2 (en) * 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
US7595169B2 (en) 2005-04-27 2009-09-29 Accumetrics, Inc. Method for determining percent platelet aggregation
US7205115B2 (en) 2005-04-28 2007-04-17 Accumetrics, Inc. Method and system for stabilization of arachidonic acid for use in platelet function assay
WO2007007588A1 (ja) 2005-07-08 2007-01-18 Ono Pharmaceutical Co., Ltd. 平面性を有する環状基を母核とする化合物
US20080299587A1 (en) * 2007-05-03 2008-12-04 Dennis Durbin Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
CN101855365A (zh) 2007-11-30 2010-10-06 科贝特研究私人有限公司 热循环装置

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107430645A (zh) * 2015-04-08 2017-12-01 皇家飞利浦有限公司 用于重症监护病房中的实验室值自动化分析和风险通知的系统
CN105203752A (zh) * 2015-11-05 2015-12-30 上海中山医疗科技发展公司 一种磁性血小板吸附颗粒及其制备方法
CN105717263A (zh) * 2016-03-04 2016-06-29 北京乐普医疗科技有限责任公司 一种检测噻吩并吡啶类抗血小板药物疗效的试剂卡及其使用方法和应用
CN105717263B (zh) * 2016-03-04 2018-01-26 北京乐普医疗科技有限责任公司 一种检测噻吩并吡啶类抗血小板药物疗效的试剂卡及其使用方法和应用

Also Published As

Publication number Publication date
KR20100017510A (ko) 2010-02-16
EP2145192A1 (en) 2010-01-20
US20100184084A1 (en) 2010-07-22
JP5687055B2 (ja) 2015-03-18
WO2008137600A1 (en) 2008-11-13
US20070243632A1 (en) 2007-10-18
US9506938B2 (en) 2016-11-29
JP2010526300A (ja) 2010-07-29

Similar Documents

Publication Publication Date Title
JP5687055B2 (ja) 薬剤溶出性ステントで処理された個体の血小板反応性を評価する方法
US8574828B2 (en) Controlled platelet activation to monitor therapy of ADP antagonists
EP2153235B1 (en) Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
JP7246559B2 (ja) 凝固分析を使用した抗凝固剤の検出および分類
US7595169B2 (en) Method for determining percent platelet aggregation
Breet et al. High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events
Gurbel et al. Platelet activation in myocardial ischemic syndromes
JP6526717B2 (ja) 線維素溶解及び線溶亢進を検出するための方法及び試薬
CN1784604A (zh) 监测血小板抑制的方案
US10139421B2 (en) Detection of restensosis risk in patients receiving a stent
Yaoi et al. Role of red blood cells in the anemia‐associated bleeding under high shear conditions
Sellborn et al. Methods for research on immune complement activation on modified sensor surfaces
US7205115B2 (en) Method and system for stabilization of arachidonic acid for use in platelet function assay
US20050019742A1 (en) Methods for assessment of platelet aggregation
WO2000073792A1 (en) Control for methods for determining platelet count and platelet function
Zheng et al. Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) study
Van Werkum et al. Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence
HK1142680A (en) Methods for measuring platelet reactivity of individuals treated with drug eluting stents
WO2002059623A2 (en) Methods for determining platelet activity with antiplatelet compositions
Van Werkum et al. Point-of-care platelet function testing in patients undergoing PCI: between a rock and a hard place
EP1851541A1 (en) Platelet-derived microparticles as a novel diagnosis maker for a cardiovascular disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1142680

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100331

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1142680

Country of ref document: HK